2772-9737

Continence

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2253 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2253 DOIs
2

Attach ORCID iDs across 1983 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1983 DOIs
3

Deposit reference lists for 1149 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact1149 DOIs

DOIs for this ISSN

Showing the top 5 of 2253 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 1 PROSPECTIVE MULTI CENTER REGISTRY FOR PATIENTS UNDERGOING… (10.1016/j.cont.2022.100191)
Abstract References ORCID
58.36 5
2 The history of neuromodulation for lower urinary tract dysfu… (10.1016/j.cont.2024.101328)
Abstract ORCID
42.25 6
3 FIRST IN MAN IMPLANTATION OF THE NEW ARTIFICIAL URINARY SPHI… (10.1016/j.cont.2023.100976)
Abstract ORCID
38.91 5
4 14 - Comparison of sacrocolpopexy versus lateral colposuspen… (10.1016/j.cont.2022.100055)
Abstract References ORCID
35.78 2
5 51 - A drug-coated balloon treatment (Optilume©) for urethra… (10.1016/j.cont.2023.100649)
Abstract References ORCID
35.78 2
6 LOWER URINARY TRACT SYMPTOMS IN AFRICA: PREVALENCE, GEOGRAPH… (10.1016/j.cont.2023.100832)
Abstract References ORCID
35.78 2
7 166 - Effects of GLP-1 Receptor Agonists on Testosterone Lev… (10.1016/j.cont.2025.102090)
Abstract References ORCID
35.78 2
8 Sacral neuromodulation for faecal incontinence (10.1016/j.cont.2024.101695)
Abstract ORCID
34.95 4
9 PILOT SINGLE-MASKED, RANDOMIZED, 3-ARM PARALLEL STUDY ASSESS… (10.1016/j.cont.2023.100778)
Abstract ORCID
30.10 3
10 SALT AND WATER TRANSPORT ACROSS THE HUMAN BLADDER WALL (10.1016/j.cont.2023.100812)
Abstract ORCID
30.10 3
11 MAXIMUM URETHRAL CLOSURE PRESSURE AS A PREDICTOR OF SUCCESS… (10.1016/j.cont.2023.100930)
Abstract ORCID
30.10 3
12 Summary of the 2023 report of the international consultation… (10.1016/j.cont.2023.101056)
Abstract
30.10 15
13 Psychiatric disorders in patients with lower urinary tract s… (10.1016/j.cont.2023.100589)
Abstract
28.65 13
14 Lower urinary tract dysfunction in uncommon neurological dis… (10.1016/j.cont.2022.100022)
Abstract
27.85 12
15 Methods used to investigate tone of pelvic floor muscles in… (10.1016/j.cont.2023.100593)
Abstract
26.98 11
16 Prevalence of co-existing pelvic floor disorders: A scoping… (10.1016/j.cont.2022.100028)
Abstract
26.03 10
17 Effects of vasopressin receptor agonists on detrusor smooth… (10.1016/j.cont.2022.100032)
Abstract
26.03 10
18 Management of bladder spasms in patients with indwelling uri… (10.1016/j.cont.2023.100713)
Abstract
26.03 10
19 Multidisciplinary team (MDT) approach to pelvic floor disord… (10.1016/j.cont.2023.100716)
Abstract
26.03 10
20 Clinical assessment, conservative management, specialized di… (10.1016/j.cont.2023.101063)
Abstract
26.03 10
21 What do we really know about the external urethral sphincter… (10.1016/j.cont.2024.101223)
Abstract
26.03 10
22 ICS-SUFU standard: Theory, terms, and recommendations for pr… (10.1016/j.cont.2023.100709)
Abstract
25.00 9
23 Pudendal nerve stimulation for treatment of lower urinary tr… (10.1016/j.cont.2024.101685)
Abstract
25.00 9
24 Single system ectopic ureters: Adult presentation of a conge… (10.1016/j.cont.2022.100016)
Abstract ORCID
23.86 2
25 2 SINGLE INTRASPHINCTERIC INJECTION OF AUTOLOGOUS ADIPOSE-DE… (10.1016/j.cont.2022.100192)
Abstract ORCID
23.86 2
26 11 UCON; A NONINVASIVE NEUROSTIMULATION SYSTEM SPECIFICALLY… (10.1016/j.cont.2022.100201)
Abstract ORCID
23.86 2
27 27 MAST CELLS IN THE URINARY BLADDERS OF INTERSTITIAL CYSTIT… (10.1016/j.cont.2022.100217)
Abstract ORCID
23.86 2
28 274 A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND… (10.1016/j.cont.2022.100340)
Abstract ORCID
23.86 2
29 426 ONABOTULINUMTOXIN A TO BLADDER NECK: MINIMALLY INVASIVE… (10.1016/j.cont.2022.100400)
Abstract ORCID
23.86 2
30 487 SACRAL NEUROMODULATION IN PEDIATRIC POPULATION: WHAT WE… (10.1016/j.cont.2022.100438)
Abstract ORCID
23.86 2
31 The International Continence Society (ICS) survey on intermi… (10.1016/j.cont.2023.100597)
Abstract
23.86 8
32 CHANGES IN BRAIN STEM FUNCTIONAL CONNECTIVITY PATTERNS BETWE… (10.1016/j.cont.2023.100758)
Abstract ORCID
23.86 2
33 OUTCOMES OF SIMULTANEOUS MODIFIED POSTERIOR COLPORRHAPHY AFT… (10.1016/j.cont.2023.100775)
Abstract ORCID
23.86 2
34 EFFECT OF ULTRASOUND-GUIDED DRY NEEDLING ON PELVIC PAIN, BLA… (10.1016/j.cont.2023.100813)
Abstract ORCID
23.86 2
35 ONLINE GROUP-BASED PELVIC FLOOR MUSCLE TRAINING FOR URINARY… (10.1016/j.cont.2023.100947)
Abstract ORCID
23.86 2
36 WHEN CAN WE EXPECT CLINICALLY IMPORTANT DIFFERENCES FROM PEL… (10.1016/j.cont.2023.101005)
Abstract ORCID
23.86 2
37 Unraveling the complexity of bladder-centric chronic pain by… (10.1016/j.cont.2023.101041)
Abstract
23.86 8
38 Lower urinary tract dysfunction in uncommon neurological dis… (10.1016/j.cont.2023.101043)
Abstract
23.86 8
39 Management using continence products: Report of the 7th Inte… (10.1016/j.cont.2023.101049)
Abstract
23.86 8
40 ICS educational module: The practice of uroflowmetry in adul… (10.1016/j.cont.2023.101065)
Abstract
23.86 8
41 Long term safety outcomes and continuation rates of repeated… (10.1016/j.cont.2023.101066)
Abstract
23.86 8
42 26 - Endogenous production of arginine vasopressin in the mo… (10.1016/j.cont.2024.101368)
Abstract ORCID
23.86 2
43 85 - Why " Water-tight" Bladder is Averse to Osmosis But Ame… (10.1016/j.cont.2024.101427)
Abstract ORCID
23.86 2
44 137 - The new artificial urinary sphincter UroActive™ (UroMe… (10.1016/j.cont.2024.101479)
Abstract ORCID
23.86 2
45 Complications associated with the use of mesh to treat femal… (10.1016/j.cont.2024.101713)
Abstract
23.86 8
46 112 - Ignorance of Timing Imperils Bladder Permeability Assa… (10.1016/j.cont.2025.102036)
Abstract ORCID
23.86 2
47 20 - Thulium laser ablation for posterior urethral valves: E… (10.1016/j.cont.2022.100061)
Abstract References ORCID
22.58 1
48 33 - Bulbospongiosus muscle-sparing AdVanceXP Male Sling pla… (10.1016/j.cont.2022.100074)
Abstract References ORCID
22.58 1
49 41 - Short-term outcomes of water vapor therapy (Rezum®) for… (10.1016/j.cont.2022.100082)
Abstract References ORCID
22.58 1
50 76 DIFFERENTIAL INTERACTION BETWEEN VAGINAL FIBROBLASTS AND… (10.1016/j.cont.2022.100244)
Abstract References ORCID
22.58 1